Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Short Interest Update

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) experienced a notable reduction in short interest during January. As of January 31st, the total short interest amounted to 6,337,300 shares, representing a decrease of 9.0% compared to the January 15th figure of 6,962,300 shares. Given an average trading volume of 1,348,400 shares, the current days-to-cover ratio stands at 4.7 days.

Wall Street Analyst Opinions

Curaleaf has recently been featured in various analysts' reports. For instance, Cormark downgraded its rating on Curaleaf from "moderate buy" to "hold" on November 7th. Conversely, Roth Capital upgraded the company to a "strong-buy" rating on November 10th.

Curaleaf Stock Performance

On Monday, Curaleaf's stock saw a decline of 1.3%, dropping by $0.02 to a trading price of $1.48. During this session, approximately 406,433 shares changed hands, in contrast to its average trading volume of 791,787 shares. The stock has a 50-day simple moving average of $1.50 and a 200-day simple moving average of $2.35. Over the past year, Curaleaf reached a low of $0.88 and a high of $6.40. Financially, the company shows a quick ratio of 0.51, a current ratio of 1.11, and a debt-to-equity ratio of 0.85. Its market capitalization stands at around $971.01 million, with a PE ratio of -5.10 and a beta of 0.60.

Overview of Curaleaf

Curaleaf Holdings, Inc. operates in the cannabis sector across the United States, offering a wide range of products. It is divided into two main segments: Domestic Operations and International Operations. The company provides various cannabis products, including flowers, pre-rolls, vaporizers, concentrates, edibles, and topical items.

Additional Information

• Five stocks that may outperform Curaleaf.
• Procter & Gamble's recent performance and guidance.
• The implications of Airbnb's latest earnings report.
• Understanding the importance of brokerage rankings in stock selection.
• Recent growth in Kyndryl's AI and cybersecurity segments.
• First-time buying stocks: a straightforward guide.
• Examining conflicting indicators in Tempus AI's stock performance.

Investment Considerations

Before making any investment decisions regarding Curaleaf, investors may want to consider the opinions of top analysts and compare them against other market options. Curaleaf currently holds a "Buy" rating, yet analysts have identified alternative stocks that may offer more potential.

Curaleaf, Stocks, Cannabis